Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Epigral Ltd

| Q4 FY26 Conference Call

BULLISH SENTIMENT

Report Source

⬤6th May 26

Summary : Epigral reported strong Q4 FY26 results with record revenue and improved margins, driven by volume growth and operational efficiency, anticipating continued growth and strategic expansions.

Management Perspective positive : "However, we are positive on the demand growth of India.""Our capacity expansion projects... are progressing on track and within budget.""We are confident to grow with the volume growth of 10% to 12%.""FY '27 looks much better than FY '26 based on that...""We are targeting consistent growth."

Concall Report Analysis & Insights

Business Overview

  1. Achieved highest ever Q4 FY26 revenue of INR 736 crores.
  2. Q4 EBITDA margin normalized to 23% due to better utilization.
  3. Full-year revenue INR 2,542 crores, EBITDA margin 22%.
  4. Net debt to EBITDA 0.9, up from 0.7 last year.
  5. Caustic soda ECU was INR 30,000 in Q4, currently around INR 37,000.

Future Growth Prospects

  1. Targeting 10-12% volume growth for FY27.
  2. Epichlorohydrin and CPVC capacity expansions are on track.
  3. Chlorotoluene facility aiming for optimum utilization by FY28.
  4. New greenfield project under evaluation, announcement expected this year.
  5. Expect 90-95% chlorine captive consumption by FY28.

Management Insights

  1. Q4 FY26 was a volatile but critical quarter.
  2. Demand picked up from mid-November into Q4.
  3. Diversified product portfolio provides market resilience.
  4. Optimizing projects for steady growth and integration.
  5. Expect FY27 to be better than FY26 in volume.

Signs of Skepticism

  1. Management avoided specific FY27 EBITDA margin guidance.
  2. Specific product price realization numbers were not provided.
  3. New greenfield project announcement has been delayed.
  4. Uncertainty regarding war's impact on prices.
  5. High PVC price volatility makes predictions difficult.

Risk Factors

  1. West Asia conflict disrupted global supply chains.
  2. Inflationary pressures on raw materials expected.
  3. Monsoon conditions can impact product demand.
  4. Currency depreciation affects foreign exchange derivatives.
  5. Volatility in PVC prices creates market uncertainty.

Good To Know

  1. US reduced tariffs, China removed VAT export rebates.
  2. Caustic soda plant ran optimally after Q3 maintenance.
  3. Current wind-solar energy share is 8-9%, expanding to 15%.
  4. Chlorotoluene serves agrochemical and pharmaceutical segments.
  5. Interest cost increase due to mark-to-market impact.

Key Drivers

  1. Strong Q4 performance, record revenue.
  2. 10-12% volume growth expected FY27.
  3. Epichlorohydrin and CPVC expansions on track.
  4. New greenfield project announcement soon.

Key Analyst Discussions

Competitive Environment

  1. Impact of West Asia conflict on company revenues.
  2. Competitive landscape for CPVC products.
  3. Insulation from global energy cost escalation.

Market Trends & Consumer Behavior

  1. Demand pickup from mid-November.
  2. Impact of unfavorable monsoon conditions.
  3. Current trend of CPVC prices.
  4. Overall volume trends from Indian and export markets.

Financial Highlights

  1. Questions on caustic soda ECU and price realizations.
  2. Inquiry about FY27 revenue growth and EBITDA margins.
  3. Discussion on increased interest costs and reasons.

Product Composition

  1. Revenue contribution from derivatives and specialty business.
  2. Current and future internal chlorine consumption.
  3. Ramp-up and utilization of new CPVC and ECH capacity.
  4. Highest product line with price inflation.

Strategic Considerations

  1. FY27 volume growth and capacity addition guidance.
  2. Plans for CPVC products, target customers, market.
  3. Status and timeline of new greenfield project.
  4. Mitigating risks from unfavorable monsoon conditions.
  5. Plans for expanding caustic soda capacity.
Epigral Ltd (EPIGRAL) Concall Report Analysis & Insights | Dhanarthi